UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The P2X7 receptor–NLRP3 inflammasome complex predicts the development of non‐Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single‐centre study

Journal of internal medicine, 2017-08, Vol.282 (2), p.175-186

2017

Volltextzugriff (PDF)

The P2X7 receptor–inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome

Journal of internal medicine, 2013-11, Vol.274 (5), p.480-489

2013

Volltextzugriff (PDF)

Outcomes of long-term responders to anti-programmed death 1 and anti-programmed death ligand 1 when being rechallenged with the same anti-programmed death 1 and anti-programmed death ligand 1 at progression

European journal of cancer (1990), 2018-09, Vol.101, p.160-164

2018

Volltextzugriff (PDF)

Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study

Journal of internal medicine, 2015-08, Vol.278 (2), p.185-192

2015

Volltextzugriff (PDF)

Bridging the gap: addressing disparities of access to oncology clinical trials in the geriatric population

ESMO open, 2023-12, Vol.8 (6), p.102029-102029, Article 102029

2023

Volltextzugriff (PDF)

Patients’ selection and trial matching in early-phase oncology clinical trials

Critical reviews in oncology/hematology, 2024-04, Vol.196, p.104307-104307, Article 104307

2024

Volltextzugriff (PDF)

Infections occurring following IL6 blockade for the management of cytokine release syndrome in onco-hematology patients

Cancer chemotherapy and pharmacology, 2023-09, Vol.92 (3), p.229-233

2023

Volltextzugriff (PDF)

Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease

Seminars in arthritis and rheumatism, 2020-10, Vol.50 (5), p.846-853

2020

Volltextzugriff (PDF)

A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome

Lupus, 2015-03, Vol.24 (3), p.315-320

2015

Volltextzugriff (PDF)

Interplay of anti‐SSA/SSB status and hypertension in determining cardiovascular risk in primary Sjögren’s syndrome

Journal of internal medicine, 2020-02, Vol.287 (2), p.214-215

2020

Volltextzugriff (PDF)

One year in review 2017: systemic vasculitis

Clinical and experimental rheumatology, 2017-03, Vol.35 Suppl 103 (1), p.5

2017

Volltextzugriff (PDF)

Immunotherapy phase I trials in patients Older than 70 years with advanced solid tumours

European journal of cancer (1990), 2018-05, Vol.95, p.68-74

2018

Volltextzugriff (PDF)

OP0291 SEVERITY OF LABIAL MINOR SALIVARY GLAND FOCUS SCORE AND FUTURE LYMPHOMA DEVELOPMENT IN SJÖGREN’S SYNDROME

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.178-179

2021

Volltextzugriff (PDF)

Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?

Annals of oncology, 2021-07, Vol.32 (7), p.936-937

2021

Volltextzugriff (PDF)

Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort

Breast cancer research and treatment, 2022-02, Vol.191 (3), p.577-587

2022

Volltextzugriff (PDF)

Risks and benefits of phase 1 clinical trials for patients with relapsed or refractory lymphoma, from 2008 to 2023

Hematological oncology, 2023-06, Vol.41 (S2), p.600-601

2023

Volltextzugriff (PDF)

THU0264 MYELOID MALIGNANCIES, SYSTEMIC AUTOIMMUNE DISEASES AND CARDIOVASCULAR RISK: AN UNDER-REPORTED ASSOCIATION?

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.359-359

2020

Volltextzugriff (PDF)

OP0135 SAFETY AND EFFICACY OF SUBCUTANEOUS BELIMUMAB AND INTRAVENOUS RITUXIMAB COMBINATION IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME: A PHASE 2, RANDOMISED, PLACEBO-CONTROLLED 68-WEEK STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.78-79

2021

Volltextzugriff (PDF)

FRI0323 A “Composite-Index” Approach for Defining Salivary Gland Inflammation, Dysfunction and Its Impact on Patient-Reported Outcomes: A Role for Salivary Gland Ultrasonography?

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.552-552

2016

Volltextzugriff (PDF)

FRI0161 PHENOTYPIC DIFFERENCES BETWEEN SJÖGREN’S SYNDROME PATIENTS WITH LOW AND HIGH-GRADE INFLAMMATION BASED ON SALIVARY GLAND FOCUS SCORE

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.664-664

2020

Volltextzugriff (PDF)

Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome

Clinical and experimental rheumatology, 2012-09, Vol.30 (5), p.785

2012

Volltextzugriff (PDF)

Safety profile of epigenetic therapies in early phase trials: Do epidrugs deserve specific drug development processes?

Annals of oncology, 2019-02, Vol.30 Suppl 1, p.i5

2019

Volltextzugriff (PDF)

Applicability of the lung immune prognostic index (LIPI) in patients with metastatic solid tumors when treated with immune checkpoint inhibitors (ICI) in early clinical trials

Annals of oncology, 2019-02, Vol.30 Suppl 1, p.i2

2019

Volltextzugriff (PDF)

Rhupus syndrome: Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients

Autoimmunity reviews, 2013-02, Vol.12 (4), p.537-541

2013

Volltextzugriff (PDF)

Safety and efficacy of folfirinox in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2017-01, Vol.17 (1), p.146-149

2017

Volltextzugriff (PDF)

1 – 25 von 3.865

Suche als RSS-Feed

Aktive Filter

ThemaAstronomy & Astrophysics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.428)
Mit Volltextzugriff
(3.387)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(2.250)
Springer journals
(1.054)
IngentaConnect
(1.004)
Publisher or Other Site
(926)
MEDLINE
(819)
Journals@OVID
(679)
Elsevier ScienceDirect Journals Complete
(649)
American Physical Society
(595)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(539)
PROLA - Physical Review Online Archive
(472)
IngentaConnect Journals
(370)
Wiley Journals
(194)
Wiley Online Library
(168)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(115)
Oxford journals
(87)
BMJ
(84)
eBooks on EBSCOhost
(78)
Ebook Central Perpetual and DDA
(77)
BMJ Journals Archiv - DFG Nationallizenzen
(76)
Oxford Journals 2020 Medicine
(73)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The P2X7 receptor–NLRP3 inflammasome complex predicts the development of non‐Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single‐centre study

The P2X7 receptor–inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome

Outcomes of long-term responders to anti-programmed death 1 and anti-programmed death ligand 1 when being rechallenged with the same anti-programmed death 1 and anti-programmed death ligand 1 at progression

Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study

Bridging the gap: addressing disparities of access to oncology clinical trials in the geriatric population

Patients’ selection and trial matching in early-phase oncology clinical trials

Infections occurring following IL6 blockade for the management of cytokine release syndrome in onco-hematology patients

Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease

A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome

Interplay of anti‐SSA/SSB status and hypertension in determining cardiovascular risk in primary Sjögren’s syndrome

One year in review 2017: systemic vasculitis

Immunotherapy phase I trials in patients Older than 70 years with advanced solid tumours

OP0291 SEVERITY OF LABIAL MINOR SALIVARY GLAND FOCUS SCORE AND FUTURE LYMPHOMA DEVELOPMENT IN SJÖGREN’S SYNDROME

Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?

Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort

Risks and benefits of phase 1 clinical trials for patients with relapsed or refractory lymphoma, from 2008 to 2023

THU0264 MYELOID MALIGNANCIES, SYSTEMIC AUTOIMMUNE DISEASES AND CARDIOVASCULAR RISK: AN UNDER-REPORTED ASSOCIATION?

OP0135 SAFETY AND EFFICACY OF SUBCUTANEOUS BELIMUMAB AND INTRAVENOUS RITUXIMAB COMBINATION IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME: A PHASE 2, RANDOMISED, PLACEBO-CONTROLLED 68-WEEK STUDY

FRI0323 A “Composite-Index” Approach for Defining Salivary Gland Inflammation, Dysfunction and Its Impact on Patient-Reported Outcomes: A Role for Salivary Gland Ultrasonography?

FRI0161 PHENOTYPIC DIFFERENCES BETWEEN SJÖGREN’S SYNDROME PATIENTS WITH LOW AND HIGH-GRADE INFLAMMATION BASED ON SALIVARY GLAND FOCUS SCORE

Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome

Safety profile of epigenetic therapies in early phase trials: Do epidrugs deserve specific drug development processes?

Applicability of the lung immune prognostic index (LIPI) in patients with metastatic solid tumors when treated with immune checkpoint inhibitors (ICI) in early clinical trials

Rhupus syndrome: Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients

Safety and efficacy of folfirinox in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis

Aktive Filter

Suchergebnisse filtern